The Saudi Arabia region is witnessing a significant shift in the landscape of cancer care, driven by the increasing demand for affordable and accessible treatment options. Within this context, the generic oncology drug market in SAUDI ARABIA is emerging as a key player, offering therapeutically equivalent alternatives to branded medications at lower costs. According to the UnivDatos Market...